Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Turnstone Biologics Corp. (TSBX) since 2023 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Turnstone Biologics Corp.. Table 2 shows the detailed insider transactions. This company's CIK number is 1764974.
Total stock buying since 2023: $15,399,984.
Total stock sales since 2023: $0.
Total stock option exercises since 2023: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2023 | 1,283,332 | $15,399,984 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2023-07 | 1,283,332 | $15,399,984 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-07-25 | Versant Vantage Ii, L.p. (10% Owner) | Buy | 225,000 | 12.00 | 2,700,000 |
2023-07-25 | Jerel Davis (Director) | Buy | 225,000 | 12.00 | 2,700,000 |
2023-07-20 | Orbimed Capital Gp Vi Llc | Buy | 416,666 | 12.00 | 4,999,992 |
2023-07-20 | Gupta Rishi | Buy | 416,666 | 12.00 | 4,999,992 |
Insider trading activities including stock purchases, stock sales, and option exercises of TSBX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Turnstone Biologics Corp. (symbol TSBX, CIK number 1764974) see the Securities and Exchange Commission (SEC) website.